Amgen And The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The First Amgen Golden Ticket To BioLabs LA Read more about Amgen And The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The First Amgen Golden Ticket To BioLabs LA
Amgen To Present At The 2021 Bank of America Merrill Lynch Global Healthcare Conference Read more about Amgen To Present At The 2021 Bank of America Merrill Lynch Global Healthcare Conference
Amgen To Webcast Investor Call At ESMO 2021 Read more about Amgen To Webcast Investor Call At ESMO 2021
Amgen To Showcase New Data From Inflammation Portfolio At EADV Virtual Congress 2021 Read more about Amgen To Showcase New Data From Inflammation Portfolio At EADV Virtual Congress 2021
Amgen to Present at the 19th Annual Morgan Stanley Global Healthcare Conference Read more about Amgen to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
Amgen Presents New Data From Thoracic Oncology Portfolio At WCLC21 Read more about Amgen Presents New Data From Thoracic Oncology Portfolio At WCLC21
New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps Read more about New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And Comorbid Nasal Polyps
Amgen to Present at the 16th Annual Citi BioPharma Conference Read more about Amgen to Present at the 16th Annual Citi BioPharma Conference
New Data At ESC Congress 2021 Shows Repatha® (evolocumab) Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome (ACS) Read more about New Data At ESC Congress 2021 Shows Repatha® (evolocumab) Improves Features Of Plaque Stability In Patients With Acute Coronary Syndrome (ACS)
Amgen Reports Second Quarter 2021 Financial Results Read more about Amgen Reports Second Quarter 2021 Financial Results
